Massachusetts-based Boston Scientific Corporation (BSX) holds significant appeal for healthcare investors, thanks to its extensive array of specialized medical devices and products, including a broad range of implantable devices such as pacemakers, as well as essential products like catheters.
Commanding a large market cap of $123.6 billion, BSX operates in the traditionally defensive healthcare industry, operating in specialized segments that include Cardiovascular, Rhythm and Neuro, and MedSurg. As the company's leadership shifts its focus toward entering and expanding in fast-growing areas such as prostate health and therapeutic oncology to address the needs of an aging population, Boston Scientific looks strategically positioned for sustained growth.
